Aik Choon Tan
Title
Cited by
Cited by
Year
Patient-derived tumour xenografts as models for oncology drug development
JJ Tentler, AC Tan, CD Weekes, A Jimeno, S Leong, TM Pitts, JJ Arcaroli, ...
Nature reviews Clinical oncology 9 (6), 338-350, 2012
9462012
Caspase 3–mediated stimulation of tumor cell repopulation during cancer radiotherapy
Q Huang, F Li, X Liu, W Li, W Shi, FF Liu, B O'sullivan, Z He, Y Peng, ...
Nature medicine 17 (7), 860-866, 2011
6052011
Ensemble machine learning on gene expression data for cancer classification
AC Tan, D Gilbert
University of Glasgow, 2003
4202003
Simple decision rules for classifying human cancers from gene expression profiles
AC Tan, DQ Naiman, L Xu, RL Winslow, D Geman
Bioinformatics 21 (20), 3896-3904, 2005
3972005
Optimizing the detection of lung cancer patients harboring anaplastic lymphoma kinase (ALK) gene rearrangements potentially suitable for ALK inhibitor treatment
DR Camidge, SA Kono, A Flacco, AC Tan, RC Doebele, Q Zhou, L Crino, ...
Clinical Cancer Research 16 (22), 5581-5590, 2010
3542010
A DNA methylation fingerprint of 1628 human samples
AF Fernandez, Y Assenov, JI Martin-Subero, B Balint, R Siebert, ...
Genome research 22 (2), 407-419, 2012
3202012
The miR-106b-25 cluster targets Smad7, activates TGF-β signaling, and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancer
AL Smith, R Iwanaga, DJ Drasin, DS Micalizzi, RL Vartuli, AC Tan, ...
Oncogene 31 (50), 5162-5171, 2012
3082012
Postpartum mammary gland involution drives progression of ductal carcinoma in situ through collagen and COX-2
TR Lyons, J O'brien, VF Borges, MW Conklin, PJ Keely, KW Eliceiri, ...
Nature medicine 17 (9), 1109-1115, 2011
2962011
A mechanism of resistance to gefitinib mediated by cellular reprogramming and the acquisition of an FGF2-FGFR1 autocrine growth loop
KE Ware, TK Hinz, E Kleczko, KR Singleton, LA Marek, BA Helfrich, ...
Oncogenesis 2 (3), e39-e39, 2013
1942013
Tumor engraftment in nude mice and enrichment in stroma-related gene pathways predict poor survival and resistance to gemcitabine in patients with pancreatic cancer
I Garrido-Laguna, M Uson, NV Rajeshkumar, AC Tan, E De Oliveira, ...
Clinical Cancer Research 17 (17), 5793-5800, 2011
1822011
Direct reprogramming of human fibroblasts into dopaminergic neuron-like cells
X Liu, F Li, EA Stubblefield, B Blanchard, TL Richards, GA Larson, Y He, ...
Cell research 22 (2), 321-332, 2012
1712012
Robust prostate cancer marker genes emerge from direct integration of inter-study microarray data
L Xu, AC Tan, DQ Naiman, D Geman, RL Winslow
Bioinformatics 21 (20), 3905-3911, 2005
1642005
Plasma-based circulating MicroRNA biomarkers for Parkinson's disease
SK Khoo, D Petillo, UJ Kang, JH Resau, B Berryhill, J Linder, L Forsgren, ...
Journal of Parkinson's disease 2 (4), 321-331, 2012
1472012
Characterizing DNA methylation patterns in pancreatic cancer genome
AC Tan, A Jimeno, SH Lin, J Wheelhouse, F Chan, A Solomon, ...
Molecular oncology 3 (5-6), 425-438, 2009
1462009
Multi-class protein fold classification using a new ensemble machine learning approach
AC Tan, D Gilbert, Y Deville
Genome Informatics 14, 206-217, 2003
1462003
Genetic analysis of 779 advanced differentiated and anaplastic thyroid cancers
N Pozdeyev, LM Gay, ES Sokol, R Hartmaier, KE Deaver, S Davis, ...
Clinical Cancer Research 24 (13), 3059-3068, 2018
1332018
A resource for analysis of microRNA expression and function in pancreatic ductal adenocarcinoma cells
OA Kent, ME Mullendore, EA Wentzel, P López-Romero, AC Tan, ...
Cancer biology & therapy 8 (21), 2013-2024, 2009
1292009
FGFR1 mRNA and protein expression, not gene copy number, predict FGFR TKI sensitivity across all lung cancer histologies
MW Wynes, TK Hinz, D Gao, M Martini, LA Marek, KE Ware, MG Edwards, ...
Clinical cancer research 20 (12), 3299-3309, 2014
1282014
Tankyrase and the canonical Wnt pathway protect lung cancer cells from EGFR inhibition
M Casás-Selves, J Kim, Z Zhang, BA Helfrich, D Gao, CC Porter, ...
Cancer research 72 (16), 4154-4164, 2012
1252012
A patient tumor transplant model of squamous cell cancer identifies PI3K inhibitors as candidate therapeutics in defined molecular bins
SB Keysar, DP Astling, RT Anderson, BW Vogler, DW Bowles, JJ Morton, ...
Molecular oncology 7 (4), 776-790, 2013
1222013
The system can't perform the operation now. Try again later.
Articles 1–20